_version_ |
1797629006739144704
|
collection |
DOAJ
|
first_indexed |
2024-03-11T10:48:15Z
|
format |
Article
|
id |
doaj.art-a85a7294133c4235a890de0590842596
|
institution |
Directory Open Access Journal
|
issn |
2051-1426
|
language |
English
|
last_indexed |
2024-03-11T10:48:15Z
|
publishDate |
2023-11-01
|
publisher |
BMJ Publishing Group
|
record_format |
Article
|
series |
Journal for ImmunoTherapy of Cancer
|
spelling |
doaj.art-a85a7294133c4235a890de05908425962023-11-13T21:50:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0110110 Deep learning models identify key tumor microenvironment features associated with genetic signatures of UV mutagenesis and alkylating agent treatment in melanoma
|
spellingShingle |
110 Deep learning models identify key tumor microenvironment features associated with genetic signatures of UV mutagenesis and alkylating agent treatment in melanoma
Journal for ImmunoTherapy of Cancer
|
title |
110 Deep learning models identify key tumor microenvironment features associated with genetic signatures of UV mutagenesis and alkylating agent treatment in melanoma
|
title_full |
110 Deep learning models identify key tumor microenvironment features associated with genetic signatures of UV mutagenesis and alkylating agent treatment in melanoma
|
title_fullStr |
110 Deep learning models identify key tumor microenvironment features associated with genetic signatures of UV mutagenesis and alkylating agent treatment in melanoma
|
title_full_unstemmed |
110 Deep learning models identify key tumor microenvironment features associated with genetic signatures of UV mutagenesis and alkylating agent treatment in melanoma
|
title_short |
110 Deep learning models identify key tumor microenvironment features associated with genetic signatures of UV mutagenesis and alkylating agent treatment in melanoma
|
title_sort |
110 deep learning models identify key tumor microenvironment features associated with genetic signatures of uv mutagenesis and alkylating agent treatment in melanoma
|